Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors

Heparin has already been found in a variety of animal tissues but only few of them became effective sources for production of pharmaceutical preparations. Here, we correlate physical-chemical features and anticoagulant activities of structurally similar heparins employed in the past (from bovine lun...

Full description

Bibliographic Details
Main Authors: Stephan N.M.C.G. Oliveira, Ana M.F. Tovar, Francisco F. Bezerra, Adriana A. Piquet, Nina V. Capillé, Paloma S. Santos, Eduardo Vilanova, Paulo A.S. Mourão
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2022-10-01
Series:TH Open
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-1946-0325
_version_ 1828106633030402048
author Stephan N.M.C.G. Oliveira
Ana M.F. Tovar
Francisco F. Bezerra
Adriana A. Piquet
Nina V. Capillé
Paloma S. Santos
Eduardo Vilanova
Paulo A.S. Mourão
author_facet Stephan N.M.C.G. Oliveira
Ana M.F. Tovar
Francisco F. Bezerra
Adriana A. Piquet
Nina V. Capillé
Paloma S. Santos
Eduardo Vilanova
Paulo A.S. Mourão
author_sort Stephan N.M.C.G. Oliveira
collection DOAJ
description Heparin has already been found in a variety of animal tissues but only few of them became effective sources for production of pharmaceutical preparations. Here, we correlate physical-chemical features and anticoagulant activities of structurally similar heparins employed in the past (from bovine lung, HBL), in the present (from porcine intestine, HPI) and in development for future use (from ovine intestine, HOI). Although they indeed have similar composition, our physical-chemical analyses with different chromatography and spectrometric techniques show that both HOI and HBL have molecular size notably lower than HPI and that the proportions of some of their minor saccharide components can vary substantially. Measurements of anticoagulant activities with anti-FIIa and anti-FXa assays confirmed that HPI and HOI have potency similar each other but significantly higher than HBL. Such a lower activity of HBL has been attributed to its reduced molecular size. Considering that HOI also has reduced molecular size, we find that its increased anticoagulant potency might result from an improved affinity to antithrombin (three times higher than HBL) promoted by the high content of N,3,6-trisulfated glucosamine units, which in turn are directly involved in the heparin-antithrombin binding. Therefore, the anticoagulant activity of different heparins is driven by a balance between different physical-chemical components, especially molecular size and fine-tuning composition. Although such minor but relevant chemical differences reinforce the concept that heparins from different animal sources should indeed be considered as distinct drugs, HOI could be approved for interchangeable use with the gold standard HPI and as a suitable start material for producing new LMWHs.
first_indexed 2024-04-11T10:19:14Z
format Article
id doaj.art-2e7a794c0a5b4812b45bf16ff6289cae
institution Directory Open Access Journal
issn 2512-9465
language English
last_indexed 2024-04-11T10:19:14Z
publishDate 2022-10-01
publisher Georg Thieme Verlag KG
record_format Article
series TH Open
spelling doaj.art-2e7a794c0a5b4812b45bf16ff6289cae2022-12-22T04:29:48ZengGeorg Thieme Verlag KGTH Open2512-94652022-10-010604e309e32210.1055/a-1946-0325Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical FactorsStephan N.M.C.G. Oliveira0Ana M.F. Tovar1Francisco F. Bezerra2Adriana A. Piquet3Nina V. Capillé4Paloma S. Santos5Eduardo Vilanova6Paulo A.S. Mourão7Laboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilLaboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilLaboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilLaboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilLaboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilLaboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilLaboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilLaboratório de Tecido Conjuntivo, Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilHeparin has already been found in a variety of animal tissues but only few of them became effective sources for production of pharmaceutical preparations. Here, we correlate physical-chemical features and anticoagulant activities of structurally similar heparins employed in the past (from bovine lung, HBL), in the present (from porcine intestine, HPI) and in development for future use (from ovine intestine, HOI). Although they indeed have similar composition, our physical-chemical analyses with different chromatography and spectrometric techniques show that both HOI and HBL have molecular size notably lower than HPI and that the proportions of some of their minor saccharide components can vary substantially. Measurements of anticoagulant activities with anti-FIIa and anti-FXa assays confirmed that HPI and HOI have potency similar each other but significantly higher than HBL. Such a lower activity of HBL has been attributed to its reduced molecular size. Considering that HOI also has reduced molecular size, we find that its increased anticoagulant potency might result from an improved affinity to antithrombin (three times higher than HBL) promoted by the high content of N,3,6-trisulfated glucosamine units, which in turn are directly involved in the heparin-antithrombin binding. Therefore, the anticoagulant activity of different heparins is driven by a balance between different physical-chemical components, especially molecular size and fine-tuning composition. Although such minor but relevant chemical differences reinforce the concept that heparins from different animal sources should indeed be considered as distinct drugs, HOI could be approved for interchangeable use with the gold standard HPI and as a suitable start material for producing new LMWHs.http://www.thieme-connect.de/DOI/DOI?10.1055/a-1946-0325anticoagulantheparinlow-molecular-weight heparinphysical-chemical conceptsthromboembolism
spellingShingle Stephan N.M.C.G. Oliveira
Ana M.F. Tovar
Francisco F. Bezerra
Adriana A. Piquet
Nina V. Capillé
Paloma S. Santos
Eduardo Vilanova
Paulo A.S. Mourão
Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
TH Open
anticoagulant
heparin
low-molecular-weight heparin
physical-chemical concepts
thromboembolism
title Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
title_full Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
title_fullStr Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
title_full_unstemmed Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
title_short Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors
title_sort anticoagulant activity of heparins from different animal sources are driven by a synergistic combination of physical chemical factors
topic anticoagulant
heparin
low-molecular-weight heparin
physical-chemical concepts
thromboembolism
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-1946-0325
work_keys_str_mv AT stephannmcgoliveira anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors
AT anamftovar anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors
AT franciscofbezerra anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors
AT adrianaapiquet anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors
AT ninavcapille anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors
AT palomassantos anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors
AT eduardovilanova anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors
AT pauloasmourao anticoagulantactivityofheparinsfromdifferentanimalsourcesaredrivenbyasynergisticcombinationofphysicalchemicalfactors